ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. - Wikidata - awgldk - TriplyDB

ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review.

ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review.

http://www.wikidata.org/entity/Q37150461

about

Prevalence and risk factors for allergic rhinitis in bakers in Douala, Cameroon EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.Adherence issues related to sublingual immunotherapy as perceived by allergists.Total IgE plasma levels vary according to gender and age in Brazilian patients with allergic rhinitis Respiratory tract infection is the major cause of the ambulatory visits in children.Liposomes: a new non-pharmacological therapy concept for seasonal-allergic-rhinoconjunctivitis.Evidence of an association between the O blood group and allergic rhinitis Research needs in allergy: an EAACI position paper, in collaboration with EFA.The patient with rhinitis in the pharmacy. A cross-sectional study in real life Investigational drugs for allergic rhinitis.VTX-1463, a novel TLR8 agonist for the treatment of allergic rhinitis.Predictors of quality of life improvement in allergic rhinitis patients after sublingual immunotherapy.Quality of life is significantly impaired in nonallergic rhinitis patients.Concentration-dependent effects of PM2.5 mass on expressions of adhesion molecules and inflammatory cytokines in nasal mucosa of rats with allergic rhinitis.

P2860

Q28393846-3881BB04-E8A0-45FA-AEF6-BCED24C6642C Q30394524-6822623B-69CA-455C-AD5E-2B3CE55C08E1 Q33966098-DF0CC0E7-8CC3-4097-A48C-00658046B179 Q34628147-899D0263-0C1D-4361-AB16-64E599A1FFC9 Q35233011-7E7C70AC-69AA-4C1F-9322-7D355BB600C3 Q35675763-F4445299-F6FB-469D-9306-339C8DAACA18 Q36283110-AC15D4CC-467C-4839-9C11-6DDC2C77C8FF Q36517533-E37A03E5-667C-40ED-8360-D3F80C9177FF Q37145982-3F2B48FD-0EB3-4711-838F-D15A38FAFB30 Q37650382-04B7CC15-1D32-4194-9123-3501F71B0C1B Q37872779-444FEC1B-6A0E-4D9F-A1E7-3E50ACEEC565 Q48055170-8AF69E98-EE16-46A1-AD21-7C1B598AB324 Q48317075-75993274-9868-4E5F-91B0-15ECDF5B1EDE Q52767036-C762F5B9-E50F-4182-BFB0-4D4BBD029974

P2860

ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review.

http://www.wikidata.org/entity/Q37150461

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

ARIA-suggested drugs for aller ...... lity of life? A GA2LEN review.

@en

ARIA-suggested drugs for aller ...... lity of life? A GA2LEN review.

@nl

type

label

ARIA-suggested drugs for aller ...... lity of life? A GA2LEN review.

@en

ARIA-suggested drugs for aller ...... lity of life? A GA2LEN review.

@nl

prefLabel

ARIA-suggested drugs for aller ...... lity of life? A GA2LEN review.

@en

ARIA-suggested drugs for aller ...... lity of life? A GA2LEN review.

@nl

P1433

Q37150461-089E05D9-B197-4429-9469-ABAE58E2EDD5

P1476

Q37150461-3FFBB7B3-4F33-424B-91E9-85AA774EF3F2

P2093

Q37150461-0ADC31D9-6124-4D2F-A1C0-8A9A12590B9D

Q37150461-121831AA-CDEE-4814-B72D-97D00CE7686A

Q37150461-1E85EA46-270E-4BEC-BBE5-5C61466F1641

Q37150461-81EF894D-1B83-44ED-8320-A8E08FD222D4

Q37150461-B58C6416-D3EB-433E-A90F-446A9D9DC6E0

Q37150461-D87D3699-E029-440E-A785-E9F3B74187D4

P2860

Q37150461-0B473A81-E25E-4695-BD5A-1DDDFBD8B2FB

Q37150461-13B17CD6-F23B-4F8A-A504-23383E642EB3

Q37150461-15AE9366-CF3A-45DE-B37A-3E92DAD95B4A

Q37150461-201E1342-80B0-4C34-A1F1-3935710F7015

Q37150461-52A5787D-27B4-46E0-A6D1-E1F560494372

Q37150461-571710EF-67E7-4169-926E-5FADD5E21B7D

Q37150461-694BE3BF-8FDE-4738-9CA5-27BA21C3DEC7

Q37150461-71307F85-552F-43A5-9010-411E5AAE9012

Q37150461-892BBD7F-BE45-4FAD-A35E-1FA1469D7B00

Q37150461-8A00C611-B2F2-4F49-8A0C-03BB941C2E86

P304

Q37150461-7149A7BE-FB3D-4E48-9A7B-B1AD0EE2EA56

P31

Q37150461-9E8E82C9-48A2-4CCF-98BF-948AF158FD99

P356

Q37150461-24DFAF18-714A-43F1-B0F2-310819851941

P433

Q37150461-15FAE97D-9E5D-4423-93BC-88DE2FCD704E

P478

Q37150461-BDA985BA-9C14-4EDD-9BD0-8C824232C23E

P50

Q37150461-362C1875-16C4-4285-87FC-78EA47FD7A51

Q37150461-4805E4F0-D3ED-4DDA-AE20-413A3144684A

Q37150461-8F22F685-E097-4328-83F2-DAA8E4622FED

Q37150461-ADF0962D-DBC1-41FD-B855-575439E7592C

P577

Q37150461-53D1C110-62D4-4959-A8D7-4CCADCA6D3A0

P5875

Q37150461-A807210D-18DB-4EC5-91E7-988E1E539FF1

P698

Q37150461-3AF55AA6-438D-4EC4-A7B5-D2B3E67DF634

P921

Q37150461-9BFF4C42-CDEC-4A4A-8F2C-FF7C92656E82

P356

J.1398-9995.2008.01649.X

P1433

P1476

ARIA-suggested drugs for aller ...... ality of life? A GA2LEN review

@en

P2093

A Porcu

http://www.w3.org/2001/XMLSchema#string

F Braido

http://www.w3.org/2001/XMLSchema#string

F Tarantini

http://www.w3.org/2001/XMLSchema#string

GA2LEN

http://www.w3.org/2001/XMLSchema#string

I Baiardini

http://www.w3.org/2001/XMLSchema#string

T Zuberbier

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

The allergy epidemic extends beyond the past few decades.

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

Sleep disturbances in allergic diseases.

Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season.

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.

Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.

Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid.

Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.

P304

660-669

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1398-9995.2008.01649.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Philippe J Bousquet

Giorgio Walter Canonica

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5407616

http://www.w3.org/2001/XMLSchema#string

P698

18445183

http://www.w3.org/2001/XMLSchema#string

P921

quality of life